Skip to main content
SpringerLink
Log in

Younger males at greatest risk of myocarditis after mRNA-based COVID-19 vaccination

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. The presence of new concerning symptoms of myocarditis, abnormal cardiac test results, with histopathological or imaging confirmation, and no other identifiable cause of the symptoms and findings.

Reference

  • Oster ME, et al. Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021. JAMA: the Journal of the American Medical Association 327: 331-340, No. 4, 25 Jan 2022. Available from: URL: http://doi.org/10.1001/jama.2021.24110

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Younger males at greatest risk of myocarditis after mRNA-based COVID-19 vaccination. Reactions Weekly 1892, 12 (2022). https://doi.org/10.1007/s40278-022-09554-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-09554-1

Search

Navigation